Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma

Authors:

Abstract
Objective. The expression of matrix metalloproteinases 2 (MMP‐2) and 9 (MMP‐9) and tissue inhibitors of matrix metalloproteinases 1 (TIMP‐1) and 2 (TIMP‐2) in vulvar intraepithelial neoplasia (VIN I–III) and in vulvar invasive carcinoma were evaluated. Design. A retrospective study. Setting. Oulu University Hospital, Finland. Sample. The study population consisted of 68 patients with vulvar neoplasia (13 VIN I, 5 VIN II, 6 VIN III and 44 squamous cell carcinomas). Methods. Paraffin‐embedded tissue samples were examined by immunohistochemistry. Main outcome measures. MMP‐2, MMP‐9, TIMP‐1 and TIMP‐2 expression in VIN compared to vulvar carcinoma. Results. In VIN I–III MMP‐2 expression was positive in 13%, MMP‐9 in 13%, TIMP‐1 in 50% and TIMP‐2 in 17% of patients. The positive expressions in patients with vulvar carcinoma were 52% for MMP‐2, 36% for MMP‐9, 41% for TIMP‐1 and 78% for TIMP‐2. Conclusions. We conclude that over‐expression of MMP‐2, MMP‐9 and TIMP‐2 may be associated with the progression from VIN to invasive vulvar squamous cell carcinoma.

This publication has 22 references indexed in Scilit: